Text Size

Sexual Functioning in Endometrial Cancer

This study has been completed.
Sponsor:
Information provided by:
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT00543192
First received: October 10, 2007
Last updated: September 2, 2009
Last verified: September 2009
History of Changes
  Purpose

The purpose of this study is estimate how sexual function in endometrial cancer survivors varies with severity of disease.


Condition
Endometrial Cancer
Sexual Function

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Sexual Functioning in Endometrial Cancer Survivors

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of Wisconsin, Madison:

Primary Outcome Measures:
  • Female Sexual Function Index (FSFI). [ Time Frame: at time of enrollment ] [ Designated as safety issue: No ]

Enrollment: 73
Study Start Date: October 2007
Study Completion Date: June 2009
Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   19 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

University of Wisconsin Gynecologic Oncology and Radiation Oncology Clinics

Criteria

Inclusion Criteria:

  • History of Stage I-IIIA endometrial adenocarcinoma of any grade
  • 1-5 years out from primary surgical treatment
  • Adjuvant therapy may only have consisted of radiation or hormonal therapy
  • No evidence of disease

Exclusion Criteria:

  • Previous treatment for other malignancies
  • Did not undergo surgery for primary treatment of endometrial cancer
  • Inability to read, write and speak fluent English
  • Major cognitive impairment affecting ability to provide consent
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00543192

Locations
United States, Wisconsin
University of Wisconsin School of Medicine and Public Health
Madison, Wisconsin, United States, 53792
Sponsors and Collaborators
University of Wisconsin, Madison
Investigators
Principal Investigator: David M Kushner, MD University of Wisconsin, Madison
  More Information

No publications provided by University of Wisconsin, Madison

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: David M. Kushner, University of Wisconsin
ClinicalTrials.gov Identifier: NCT00543192     History of Changes
Other Study ID Numbers: CC 07703, H-2007-0204
Study First Received: October 10, 2007
Last Updated: September 2, 2009
Health Authority: United States: Institutional Review Board

Keywords provided by University of Wisconsin, Madison:
Endometrial Cancer
Sexual Function

Additional relevant MeSH terms:
Endometrial Neoplasms
Sarcoma, Endometrial Stromal
Adenoma
Uterine Neoplasms
Genital Neoplasms, Female
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
 Uterine Diseases
Genital Diseases, Female
Neoplasms, Complex and Mixed
Neoplasms by Histologic Type
Sarcoma
Neoplasms, Connective and Soft Tissue
Endometrial Stromal Tumors
Neoplasms, Glandular and Epithelial

ClinicalTrials.gov processed this record on May 23, 2013